Results 231 to 240 of about 19,226,899 (298)

Machine learning-based prediction of HCV-related cirrhosis and the exploratory analysis of drug use influence. [PDF]

Front Public Health
Gu S, Ye L, Tang J, Qian W, Hu Z, Ma X, Chen A, Zheng Q, Wang L, Yin G, Yi C.   +10 more
europepmc   +1 more source

Reduction of immunosuppressants fails to clear hepatitis E virus infection in a heart transplant recipient. [PDF]

IDCases
Chen Z, Niu W, Li G, Chen X, Chen S, Zhang K, Fang M, Wang Y, Fu L, Zheng Z, Xia N.   +10 more
europepmc   +1 more source

MDL-001: An Oral, Direct-Acting Broad-Spectrum Antiviral for Influenza-like Illness (ILI) and Chronic Hepatitis In Vivo. [PDF]

Pharmaceuticals (Basel)
Woods V, Umansky T, Russell SM, Goodman A, Bobardt M, McGovern BL, Rosales R, Rodriguez ML, van Bakel H, Sordillo EM, Simon V, García-Sastre A, White KM, Gallay P, Smith D, Haders D.   +15 more
europepmc   +1 more source

A Novel Quantitative ELISA Demonstrates Lack of Correlation Between Serum HDV-RNA and Anti-HDV Antibody Levels in Chronic HDV Infection. [PDF]

J Viral Hepat
Ariungerel N, Otgonbaatar K, Enkhjargal S, Erdembileg U, Byambabaatar S, Munkhjin B, Tsagaantsooj T, Enkhtaivan S, Ochirsum B, Bat-Ulzii P, Ochirbat E, Dashdorj N, Oidovsambuu O.   +12 more
europepmc   +1 more source

PIVKA-II and hematological parameters in hepatocellular carcinoma and non-malignant chronic liver disease: A case-control biomarker comparison in a hepatitis-endemic population. [PDF]

PLoS One
Hashmi MS, Ilyas MA.
europepmc   +1 more source

A Randomized, Double-Blind, Placebo-Controlled Study of the PD-1 Inhibitor Cetrelimab in Chronic Hepatitis B. [PDF]

J Viral Hepat
Asselah T, Kakuda TN, Kulke S, Walenta E, Halter RJ, Ariyawansa J, Verheijden S, Lenz O, Aguilar Z, Lonjon-Domanec I, Biermer M.   +10 more
europepmc   +1 more source

Systematic STI screening in unaccompanied migrant minors: a 6-year experience with urine-based NAAT. [PDF]

Eur J Pediatr
Milkova-Ivanova S, Mellado-Sola I, Bravo-Queipo-de-Llano B, Rodríguez-Molino P, Grasa C, García-López-Hortelano M, Quiles-Melero I, Ruiz-Bastián MD, Maldonado-Barrueco A, Calvo C, Sainz T.   +10 more
europepmc   +1 more source

Sex Disparities in Hepatitis C Treatment Initiation: Role of Universal Access to DAA in France (ANRS FANTASIO 2). [PDF]

Liver Int
Marcellin F, Ramier C, Brouard C, Di Beo V, Allier Y, Mourad A, Bureau-Stoltmann M, Sogni P, Deuffic-Burban S, Carrieri P, Rolland B, Bourliere M, Protopopescu C.   +12 more
europepmc   +1 more source

APRI and FIB-4 for Liver Fibrosis Assessment in Chronic Hepatitis B: Evidence from a Hyperendemic Andean Setting. [PDF]

Med Sci (Basel)
Cordero Vargas CC, Huaman Huallanca EY, Ango-Aguilar H, Marín-Sánchez O, Chacón RD, Ango-Bedriñana JH.   +5 more
europepmc   +1 more source